APPLICATION
ANDA074322
TYPE
ANDA
ORIGINAL APPROVAL
1996-02-13
LATEST ACTION
2015-10-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CAPTOPRILDiscontinued
CAPTOPRIL 12.5MG · TABLET · ORAL
CAPTOPRILDiscontinued
CAPTOPRIL 100MG · TABLET · ORAL
CAPTOPRILDiscontinued
CAPTOPRIL 25MG · TABLET · ORAL
CAPTOPRILDiscontinued
CAPTOPRIL 50MG · TABLET · ORAL
Approval history
2015-10-30Labeling · Supplement 22 · standardAP
2015-01-20Labeling · Supplement 21 · standardAP
2009-03-20Labeling · Supplement 20AP
2006-04-04Labeling · Supplement 18AP
2000-01-27Labeling · Supplement 10AP
1999-07-30Manufacturing (CMC) · Supplement 7AP
1997-09-29Labeling · Supplement 6AP
1997-06-10Labeling · Supplement 3AP
1996-08-06Manufacturing (CMC) · Supplement 1AP
1996-06-24Labeling · Supplement 2AP
1996-02-13OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.